Literature DB >> 7732080

Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease.

T M Cutson1, K C Laub, M Schenkman.   

Abstract

Parkinson's disease is a neurodegenerative disorder of older persons that eventually leads to disability. It is characterized by tremor, rigidity, bradykinesia, and postural instability. Progressive stages can be identified, each with unique problems. The optimal management of Parkinson's disease requires multiple professionals to address the needs of the patients as well as those of the caregivers. In addition to pharmacologic management, patients with Parkinson's disease can benefit from physical intervention and psychological support. This article summarizes strategies incorporating the multiple disciplines for each stage of the disease. [Cutson TM, Laub KC, Schenkman M. Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732080     DOI: 10.1093/ptj/75.5.363

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  5 in total

1.  The relative health related quality of life of veterans with Parkinson's disease.

Authors:  H Gage; A Hendricks; S Zhang; L Kazis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

2.  Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.

Authors:  Vasiliki Orgeta; Kathryn R McDonald; Ellen Poliakoff; John Vincent Hindle; Linda Clare; Iracema Leroi
Journal:  Cochrane Database Syst Rev       Date:  2020-02-26

3.  Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.

Authors:  Ana Lígia Silva de Lima; Tim Hahn; Luc J W Evers; Nienke M de Vries; Eli Cohen; Michal Afek; Lauren Bataille; Margaret Daeschler; Kasper Claes; Babak Boroojerdi; Dolors Terricabras; Max A Little; Heribert Baldus; Bastiaan R Bloem; Marjan J Faber
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

4.  Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial.

Authors:  Bahram Yousefi; Vahid Tadibi; Ali Fathollahzadeh Khoei; Ali Montazeri
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

5.  Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection.

Authors:  Teresa Mann; Karl Zilles; Felix Klawitter; Markus Cremer; Alexander Hawlitschka; Nicola Palomero-Gallagher; Oliver Schmitt; Andreas Wree
Journal:  Front Neuroanat       Date:  2018-08-10       Impact factor: 3.856

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.